Source: Journal of clinical endocrinology & metabolism. Unidade: FM
Subjects: HIPERTENSÃO, GLÂNDULAS SUPRARRENAIS, ALDOSTERONA, CANAIS DE POTÁSSIO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILELA, Leticia A. P et al. KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism. Journal of clinical endocrinology & metabolism, v. 104, n. 10, p. 4695-4702, 2019Tradução . . Disponível em: https://doi.org/10.1210/jc.2019-00531. Acesso em: 31 ago. 2024.APA
Vilela, L. A. P., Rassi-cruz, M., Guimaraes, A. G., Moises, C. C. S., Freitas, T. C., Alencar, N. P., et al. (2019). KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism. Journal of clinical endocrinology & metabolism, 104( 10), 4695-4702. doi:10.1210/jc.2019-00531NLM
Vilela LAP, Rassi-cruz M, Guimaraes AG, Moises CCS, Freitas TC, Alencar NP, Zerbini MCN, Xavier ACL, Mendonça BB de, Drager LF. KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism [Internet]. Journal of clinical endocrinology & metabolism. 2019 ; 104( 10): 4695-4702.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1210/jc.2019-00531Vancouver
Vilela LAP, Rassi-cruz M, Guimaraes AG, Moises CCS, Freitas TC, Alencar NP, Zerbini MCN, Xavier ACL, Mendonça BB de, Drager LF. KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism [Internet]. Journal of clinical endocrinology & metabolism. 2019 ; 104( 10): 4695-4702.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1210/jc.2019-00531